1 |
Augustson EM, Barzani D, Rutten LJF, Marcus S (2008). Gender differences among hardcore smokers: an analysis of the tobacco use supplement of the current population survey. J Women Hlth, 17, 1167-73.
DOI
ScienceOn
|
2 |
Abbasi S, Rasouli M, Nouri M, Kalbasi S (2013). Association of estrogen receptor-alpha A908G (K303R) mutation with breast cancer risk. Int J Clin Exp Med, 6, 39-49.
|
3 |
Bolton EE, Wang Y, Thiessen PA, SH B (2008). PubChem: integrated platform of small molecules and biological activities. Annu Rep Comput Chem, 4, 217-41.
DOI
|
4 |
Cheng F, Li W, Zhou Y, et al (2012). AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model, 52, 3099-105.
DOI
ScienceOn
|
5 |
Chisamore MJ, Wilkinson HA, Flores O, Chen JD (2009). Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Mol Cancer Ther, 8, 672-81.
DOI
ScienceOn
|
6 |
Choudhrya N, Deeksha K, Neha S, Aparajitac (2012). Breast cancer: a paradigm shift. Apollo Med, 9, 133-7.
DOI
ScienceOn
|
7 |
Christina TT, Peggy RT (2011). Estrogen-Related Receptors and Breast Cancer: a Mini Review. Breast Cancer-Carcinogenesis, Cell Growth and Signalling Pathways, Prof. Mehmet Gunduz (Ed.), ISBN: 978-953-307-714-7.
|
8 |
Curado MP (2011). Breast cancer in the world: incidence and mortality. Salud Publica de Mexico, 53, 372-84.
|
9 |
Dallakyan S (2008-2010). PyRx-Python Prescription v.0.8. The Scripps Research Institute.
|
10 |
DeBruin LS, Josephy PD (2002). Perspectives on the chemical etiology of breast cancer. Environ Health Perspect, 110, 119-28.
|
11 |
Divekar SD, Storchan GB, Sperle K, et al (2011). The role of calcium in the activation of estrogen receptor-alpha. Cancer Res, 71, 1658-68.
DOI
|
12 |
Duffy MJ (2001). Biochemical markers in breast cancer: which ones are clinically useful? Clin Biochem, 34, 347-52.
DOI
ScienceOn
|
13 |
Dunnwald LK, Rossing MA, Li CI (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res, 9, 6.
|
14 |
Dwyer MA, Joseph JD, Wade HE, et al (2010). WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res, 70, 9298-308.
DOI
|
15 |
Huey R, Morris GM, Olson AJ, Goodsell DS (2007). A semiempirical free energy force field with charge-based desolvation. J Comput Chem, 28, 1145-52.
DOI
ScienceOn
|
16 |
Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
DOI
ScienceOn
|
17 |
Jiang Z, Guo J, Shen J, et al (2012). The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells. J Exp Clin Cancer Res, 31, 42.
DOI
|
18 |
Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004). The KEGG resource for deciphering the genome. Nucleic Acids Res, 32, 277-80.
DOI
ScienceOn
|
19 |
Leclercq G, Lacroix M, Laios I, Laurent G (2006). Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells. Curr Cancer Drug Targets, 6, 39-64.
DOI
ScienceOn
|
20 |
Li Y, Meeran SM, Patel SN, et al (2013). Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer. Mol Cancer, 12, 9.
DOI
ScienceOn
|
21 |
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46, 3-26.
DOI
ScienceOn
|
22 |
Morris GM, Goodsell DS, Halliday RS, et al (1998) Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem, 9, 1639-62
|
23 |
Nykanen M, Kuopio T (2010). Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods. Exp Mol Pathol, 88, 265-71.
DOI
ScienceOn
|
24 |
Patch RJ, Searle LL, Kim AJ, et al (2011). Identification of diaryl ether-based ligands for estrogen-related receptor alpha as potential antidiabetic agents. J Med Chem, 54, 788-808.
DOI
ScienceOn
|
25 |
Pavao M, Traish AM (2001). Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids, 66, 1-16.
DOI
ScienceOn
|
26 |
Reiter S (2013). Barriers to effective treatment of vaginal atrophy with local estrogen therapy. Int J Gen Med, 6, 153-8.
|
27 |
Ross-Innes CS, Stark R, Holmes KA, et al (2010). Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev, 24, 171-82.
DOI
ScienceOn
|
28 |
Stein RA, Chang CY, Kazmin DA, et al (2008). Estrogen-related receptor alpha is critical for the growth of estrogen receptornegative breast cancer. Cancer Res, 68, 8805-12.
DOI
ScienceOn
|
29 |
Stein RA, Gaillard S, McDonnell DP (2009). Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. J Steroid Biochem Mol Biol, 114, 106-12.
DOI
ScienceOn
|
30 |
Stoica GE, Franke TF, Moroni M, et al (2003). Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene, 22, 7998-8011.
DOI
ScienceOn
|
31 |
Suzuki T, Miki Y, Moriya T, et al (2004). Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Res, 64, 4670-6.
DOI
ScienceOn
|
32 |
Yu CP, Ho JY, Huang YT, et al (2013). Estrogen inhibits renal cell carcinoma cell progression through estrogen receptorbeta activation. PLoS One, 8, 56667.
DOI
|
33 |
Ariazi EA, Jordan VC (2006). Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem, 6, 203-15.
DOI
|
34 |
Zhu K, Bernard LJ, Levine RS, Williams SM (1997). Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease? Med Hypotheses, 49, 69-75.
DOI
ScienceOn
|
35 |
Abdulrahman GOJr, Rahman GA (2012). Epidemiology of breast cancer in europe and Africa. J Cancer Epidemiol, 915610.
|
36 |
Ariazi EA, Clark GM, Mertz JE (2002). Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res, 62, 6510-8.
|
37 |
Bailey ST, Shin H, Westerling T, Liu XS, Brown M (2012). Estrogen receptor prevents p53-dependent apoptosis in breast cancer. Proc Natl Acad Sci USA, 109, 18060-5.
DOI
|
38 |
Barone I, Brusco L, Fuqua SA (2010). Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res, 16, 2702-8.
DOI
ScienceOn
|
39 |
Barry JB, Giguere V (2005). Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha. Cancer Res, 65, 6120-9.
DOI
ScienceOn
|
40 |
Berman HM, Henrick K, Nakamura H, et al (2007). Realism about PDB. Nat Biotechnol, 25, 845-6; author reply 846.
DOI
ScienceOn
|
41 |
Bhoo-Pathy N, Yip CH, Hartman M, et al (2013). Breast cancer research in Asia: adopt or adapt Western knowledge? Eur J Cancer, 49, 703-9.
DOI
ScienceOn
|
42 |
Bjornstrom L, Sjoberg M (2005). Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol, 19, 833-42.
DOI
ScienceOn
|